238 related articles for article (PubMed ID: 23740364)
1. Acute pulmonary embolism during warfarin therapy and long-term risk of recurrent fatal pulmonary embolism.
Moutzouris JP; Ng AC; Chow V; Chung T; Curnow J; Kritharides L
Thromb Haemost; 2013 Sep; 110(3):523-33. PubMed ID: 23740364
[TBL] [Abstract][Full Text] [Related]
2. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
3. High mortality in patients presenting with acute pulmonary embolism and elevated INR not on anticoagulant therapy.
Wong CC; Ng AC; Lau JK; Chow V; Chen V; Ng AC; Yong AS; Sindone AP; Marwick TH; Kritharides L
Thromb Haemost; 2016 Jun; 115(6):1191-9. PubMed ID: 26843127
[TBL] [Abstract][Full Text] [Related]
4. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
7. Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.
Subherwal S; Peterson ED; Chen AY; Roe MT; Washam JB; Gage BF; Bach RG; Bhatt DL; Wiviott SD; Lopes RD; Alexander KP; Wang TY
Circulation; 2012 Mar; 125(11):1414-23. PubMed ID: 22319105
[TBL] [Abstract][Full Text] [Related]
8. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
Agarwal S; Bennett D; Smith DJ
Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
[TBL] [Abstract][Full Text] [Related]
9. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
[TBL] [Abstract][Full Text] [Related]
10. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
Ripley TL; Harrison D; Germany RE; Adamson PB
Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
[TBL] [Abstract][Full Text] [Related]
12. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
13. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
Enyart JJ; Jones RJ
Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
[TBL] [Abstract][Full Text] [Related]
14. The Prevalence and Incidence of Atrial Fibrillation in Patients with Acute Pulmonary Embolism.
Ng AC; Adikari D; Yuan D; Lau JK; Yong AS; Chow V; Kritharides L
PLoS One; 2016; 11(3):e0150448. PubMed ID: 26930405
[TBL] [Abstract][Full Text] [Related]
15. [The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism].
Yang P; Wu QH; Luo XY; Kou L; Chen Z; Zhang YY; Zhou H
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1762-5. PubMed ID: 19862981
[TBL] [Abstract][Full Text] [Related]
16. Postdischarge international normalized ratio testing and long-term clinical outcomes of patients with heart failure receiving warfarin: findings from the ADHERE registry linked to Medicare claims.
Qualls LG; Greiner MA; Eapen ZJ; Fonarow GC; Mills RM; Klaskala W; Hernandez AF; Curtis LH
Clin Cardiol; 2013 Dec; 36(12):757-65. PubMed ID: 24114926
[TBL] [Abstract][Full Text] [Related]
17. Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis.
Gallus AS; Baker RI; Chong BH; Ockelford PA; Street AM
Med J Aust; 2000 Jun; 172(12):600-5. PubMed ID: 10914107
[TBL] [Abstract][Full Text] [Related]
18. Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism.
Ng AC; Yong AS; Chow V; Chung T; Freedman SB; Kritharides L
Int J Cardiol; 2013 Apr; 165(1):126-33. PubMed ID: 21864916
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of a novel patient self-management program for warfarin therapy using venipuncture-acquired international normalized ratio monitoring.
Simmons BJ; Jenner KM; Delate T; Clark NP; Kurz D; Witt DM
Pharmacotherapy; 2012 Dec; 32(12):1078-84. PubMed ID: 23112110
[TBL] [Abstract][Full Text] [Related]
20. Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).
Schwammenthal Y; Bornstein N; Schwammenthal E; Schwartz R; Goldbourt U; Tsabari R; Koton S; Grossman E; Tanne D
Am J Cardiol; 2010 Feb; 105(3):411-6. PubMed ID: 20102959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
